
To report the design, methodology, zzso and initial results of the zzso and Outcomes Study of zzso zzso zzso zzso the first US patient registry to collect and report on practice patterns and outcomes associated with zzso therapy zzso for zzso management in zzso zzso 

zzso is a prospective ongoing registry of zzso patients treated with zzso or zzso Patients from either community or academic zzso who meet zzso entry criteria are eligible for inclusion in the zzso Data collected include patient demographic and clinical zzso zzso administration, zzso zzso zzso outcomes and medical resource zzso Patients are followed from zzso initiation through to the end of therapy or 16 weeks, whichever is zzso 

zzso results from 45 sites for zzso patients zzso zzso zzso zzso zzso zzso zzso zzso showed that baseline demographic and disease characteristics were similar between the two treatment zzso Administration of zzso at both weekly and zzso or zzso intervals was observed in both groups, with similar numbers of zzso zzso However, the mean number of office visits was higher in the zzso group despite more frequent administration of therapy at zzso or zzso intervals in this zzso Mean treatment duration was approximately 8 weeks for both zzso Mean zzso zzso levels of zzso zzso were achieved and maintained at all zzso assessed with zzso but not with zzso Both groups had similar rates of packed red blood cell zzso 

The zzso zzso is a valuable source of data relating to zzso management, practice patterns and outcomes in zzso patients from the perspective of actual clinical zzso zzso from this registry should provide patients, clinicians and zzso decision makers with a better understanding of the relationship between zzso dosage and outcomes in the clinical zzso 

